Search alternatives:
ms decrease » nn decrease (Expand Search), mean decrease (Expand Search), use decreased (Expand Search)
we decrease » nn decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
16 we » 16 w (Expand Search), 1_ we (Expand Search)
ms decrease » nn decrease (Expand Search), mean decrease (Expand Search), use decreased (Expand Search)
we decrease » nn decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
16 we » 16 w (Expand Search), 1_ we (Expand Search)
-
1
-
2
SLE decreases risk for hormonal cancers.
Published 2021“…(b) Prostate cancer incidence in male SLE cohort is significantly decreased by SLE status (OR 0.23, 95% CI 0.089, 0.50, p = 0.0053).…”
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Acute myocardial infarction changes bone marrow cell composition and decreases endothelial differentiation capability.
Published 2015“…<p><b>(A)</b> CD14 positive cells increased at day 1 post-MI while the CD16 positive cell decreased at day 4 and day 7 after infarction in <b>B</b> with n ≥3 per groups. …”
-
12
-
13
-
14
-
15
-
16
DART-ID decreases missing datapoints across runs.
Published 2019“…Only peptides seen in >50% of experiments are included. (<b>b</b>) Decrease in missing data across all runs after applying DART-ID, for SCoPE-MS and the two bulk sets from <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1007082#pcbi.1007082.g004" target="_blank">Fig 4</a> at 1% FDR. …”
-
17
-
18
BMT decreases HFD-induced weight gain associated with decreased preadipocyte number and insulin secretion
Published 2017“…The application of BMT in obesity research is hampered by the significant reduction in high-fat diet (HFD)-induced obesity. We set out to characterize metabolic tissues that may be affected by the BMT procedure and impair the HFD-induced response. …”
-
19
-
20
Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.
Published 2016“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”